Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Neuren Pharmaceuticals (NEU) appoints Liza A Squires to the new position of Chief Medical Officer in the United States
  • Dr Squires is a physician in general paediatrics and neurology with special competence in child neurology
  • Over the past 20 years, she has held positions of increasing responsibilities in early and late-stage development at companies such as Johnson and Johnsons and Shire Pharmaceuticals
  • She had led and contributed to a number of new drug applications which have resulted in regulatory approvals
  • NEU is up 1.53 per cent and last traded at $3.98 per share at 2:12 pm AEST

Neuren Pharmaceuticals (NEU) has appointed Liza A Squires to the new position of Chief Medical Officer in the United States.

Dr Squires is a physician in general paediatrics and neurology with special competence in child neurology.

Over the past 20 years, she has held positions of increasing responsibilities in early and late-stage development at Johnson and Johnsons, Shire Pharmaceuticals, Lumos Pharma, Aevi Genomic Medicine and Origin Biosciences.

She had led and contributed to a number of new drug applications which have resulted in regulatory approvals.

Ms Squires trained in general paediatrics at Yale University and did her residency in Child Neurology at Massachusetts General Hospital.

“I am very pleased to welcome Liza at such an exciting time for Neuren,” CEO Jon Pilcher said.

“Her ideal skills and experience in pediatric neurology and orphan drug development will make a big difference to the team as we advance our ambitious plans for NNZ-2591 in multiple indications.”

On the market, NEU was up 1.53 per cent and last traded at $3.98 per share at 2:12 pm AEST.

NEU by the numbers
More From The Market Herald
MetalsGrove Mining (ASX:MGA) - Managing Director, Sean Sivasamy

" MetalsGrove Mining (ASX:MGA) begins soil sampling at Upper Coondina

MetalsGrove Mining (ASX:MGA) has begun a soil sampling program at its Upper Coondina lithium project in…
Bellavista Resources (ASX:BVR) - Non Executive Chairman, Mel Ashton

" Bellavista Resources (ASX:BVR) commissions second rig for Brumby, WA

Bellavista Resources (ASX:BVR) has commissioned a second rig to begin drilling at its Brumby zinc-silver-copper project…

" Sky Metals (ASX:SKY) encounters further tin mineralisation at Tallebung, NSW

Sky Metals (ASX:SKY) has reported further tin mineralisation at its Tallebung tin project in New South…
Spectur (ASX:SP3) - Managing Director, Gerard Dyson

" Spectur (ASX:SP3) raises $1.15m in SPP

Spectur (ASX:SP3) has raised $1.15 million through a security purchase plan (SPP) and shortfall offer.